Introduction
Polyarteritis nodosa is caused by an abnormal inflammatory process that targets medium-sized arteries, leading to vessel wall damage, narrowing, and reduced blood flow to tissues. In most cases, it does not arise from a single simple trigger; rather, it develops when immune-mediated injury to arteries is set in motion by factors such as hepatitis B infection, other immune disturbances, or, less commonly, an identifiable underlying condition. The disorder reflects a breakdown in normal vascular immune control, and the causes can be understood in terms of the biological mechanisms that initiate and amplify inflammation in the arterial wall.
Biological Mechanisms Behind the Condition
To understand why polyarteritis nodosa develops, it helps to begin with the normal role of arteries. Medium-sized arteries carry oxygen-rich blood to organs and tissues. Their walls are structured to withstand pressure, maintain blood flow, and respond to changes in circulation. Under healthy conditions, the immune system patrols the body without attacking these vessels. Endothelial cells lining the arteries help regulate clotting, inflammation, and vessel tone, while immune cells remain tightly controlled unless there is infection or injury.
In polyarteritis nodosa, that control fails. The arterial wall becomes a target of inflammation, usually through immune-mediated injury. Immune complexes, activated white blood cells, and inflammatory signaling molecules damage the vessel wall, particularly the inner and middle layers. This can cause thickening, weakening, and scarring of the artery. As the wall becomes inflamed, the lumen may narrow and blood flow drops. In other areas, damage can make the wall weak enough to form aneurysms. These changes explain why the disease can cause ischemia, organ dysfunction, and sometimes vessel rupture.
The disease is classically associated with necrotizing vasculitis, meaning that inflammation is severe enough to injure and kill tissue within the vessel wall. Unlike disorders that primarily involve tiny capillaries or venules, polyarteritis nodosa affects muscular arteries supplying organs such as the kidneys, intestines, nerves, skin, and heart. The pattern of injury is segmental, so one portion of an artery may be severely inflamed while another appears normal. This patchy distribution reflects how immune attack and local vascular susceptibility interact.
Primary Causes of Polyarteritis nodosa
The most strongly associated cause of polyarteritis nodosa is hepatitis B virus infection. In some individuals, the immune system forms complexes containing viral antigens and antibodies. These immune complexes circulate and deposit in arterial walls, where they activate complement and attract inflammatory cells. The resulting immune response damages the vessel wall and produces the classic vasculitic pattern. Historically, hepatitis B was a far more common cause than it is today, because vaccination and improved screening have reduced the number of new infections and chronic carriers.
Hepatitis B is important not only because it provides an antigenic trigger, but because it creates a sustained source of immune stimulation. Persistent viral proteins can continue driving the formation of immune complexes. When these complexes lodge in vessel walls, they provoke neutrophil activation, release of enzymes and reactive oxygen species, and injury to the arterial media. The inflammation is therefore not random; it is a direct consequence of how the immune system responds to viral persistence.
In many cases of polyarteritis nodosa, however, no single cause is identified. These cases are called idiopathic. Idiopathic disease likely reflects a combination of genetic susceptibility and immune dysregulation rather than a clearly detectable external trigger. In such patients, the immune system may become abnormally reactive to an unknown antigen or self-structure in the arterial wall. Even when the precise initiating event is unclear, the mechanism still centers on vessel wall inflammation and necrosis.
Less commonly, polyarteritis nodosa can occur in association with other infections or immune stimuli. These triggers may not produce the disease as frequently as hepatitis B, but they can help initiate vascular inflammation in susceptible people. In each setting, the common denominator is activation of inflammatory pathways that target medium-sized arteries.
Contributing Risk Factors
Genetic influences probably affect susceptibility, although polyarteritis nodosa is not considered a classic inherited disorder. Some people may inherit immune traits that make them more prone to exaggerated inflammatory responses or less efficient clearance of immune complexes. Variations in genes controlling complement activation, antigen presentation, or cytokine signaling could influence whether an infection or other trigger leads to persistent vascular injury. Genetics therefore appears to shape vulnerability rather than directly determine the disease.
Environmental exposures may also contribute by increasing the likelihood of infections or altering immune regulation. In areas where hepatitis B is more common, the chance of developing hepatitis B-associated vasculitis rises accordingly. Access to vaccination, sanitation, and healthcare can therefore affect disease frequency at the population level. Environmental exposure does not usually cause the vasculitis by itself, but it can determine whether a biologic trigger is present long enough to provoke immune-mediated artery damage.
Infections are the most biologically relevant external risk factor because they can provide the antigens that drive immune complex formation. Chronic or unresolved infections place continuous demand on the immune system and may increase the probability that inflammatory complexes will deposit in vessel walls. This process is especially important in hepatitis B, but the broader principle is that persistent immune activation can lead to collateral vascular injury.
Hormonal influences are not established as direct causes, yet they may affect immune function. Sex hormones can alter the balance between immune activation and immune tolerance, which may partly explain differences in inflammatory disease patterns between individuals. Any hormonal contribution is likely indirect and modest compared with infectious triggers and immune mechanisms.
Lifestyle factors are also not primary causes, but they may shape exposure risk and general immune health. For example, behaviors that increase exposure to blood-borne infections can raise the chance of hepatitis B infection. Chronic stress, poor nutrition, or other factors that influence immune resilience may affect how strongly the body responds to infection, although these are not recognized as direct causes of polyarteritis nodosa.
How Multiple Factors May Interact
Polyarteritis nodosa often develops through interaction rather than a single isolated event. A triggering infection may supply the antigenic stimulus, while genetic factors influence how the immune system reacts to it. If immune complex clearance is inefficient, these complexes remain in circulation longer and are more likely to deposit in vessel walls. Once deposited, they activate complement and recruit inflammatory cells, creating a local cycle of tissue injury.
Inflammation itself can amplify the problem. Damaged endothelial cells express signals that attract more leukocytes and increase vascular permeability. Complement activation draws additional immune mediators into the vessel wall. As the arterial wall becomes increasingly injured, it may expose structures that further stimulate immune recognition. This creates a self-reinforcing loop: immune activation damages the artery, and arterial damage fuels more inflammation.
The result is a cascade rather than a one-step event. A susceptible immune system, a provoking antigen, and a vascular target combine to produce the disease. This helps explain why some people with the same infection never develop vasculitis, while others do.
Variations in Causes Between Individuals
The cause of polyarteritis nodosa can differ substantially from one person to another because the underlying pathway is influenced by age, immune status, and exposure history. In a younger person with hepatitis B, the infection may be the dominant trigger. In another individual, especially if no infection is found, the disease may be idiopathic and likely related to less visible immune abnormalities. These differences reflect variation in both the initiating factor and the body’s response to it.
Age may influence disease causation indirectly. Immune responses change over time, and exposure patterns differ across the lifespan. Older adults may have had more opportunities for chronic infections or cumulative environmental exposure, while younger individuals may develop disease in the context of a recent infection or an as-yet-unidentified immune trigger. Age-related shifts in immune regulation can also affect how strongly the body reacts to vascular antigens.
Overall health status matters as well. People with impaired immune function, chronic infection, or other inflammatory conditions may be more prone to abnormal immune activation. The state of the liver, kidneys, and vascular endothelium can also influence how circulating immune complexes are cleared and where they deposit. Thus, the same external exposure may produce different outcomes depending on the internal physiologic environment.
Environmental exposure varies by geography, occupation, household setting, and behavior. Because hepatitis B remains more prevalent in some regions and communities than others, the causes of polyarteritis nodosa are not distributed evenly. This variability is one reason the disease may appear more often in certain populations and less often in others.
Conditions or Disorders That Can Lead to Polyarteritis nodosa
The condition most clearly linked to polyarteritis nodosa is chronic hepatitis B infection. The relationship is physiologic rather than coincidental: hepatitis B antigens combine with antibodies to form circulating immune complexes, and these complexes can lodge in arteries. Once they settle in the vessel wall, complement activation and inflammatory-cell recruitment produce necrotizing vasculitis. This mechanism makes hepatitis B not just a risk factor, but a true disease trigger in a subset of patients.
Other infections may sometimes contribute to a PAN-like vasculitic picture, although they are less classically associated than hepatitis B. In these settings, persistent antigen exposure or infection-driven immune dysregulation may initiate arterial inflammation. The common biological theme is ongoing immune stimulation that overwhelms normal vascular tolerance.
Some systemic inflammatory or autoimmune disorders can also resemble or overlap with polyarteritis nodosa, and in rare cases they may help initiate arterial injury. Even when they are not direct causes, they can create a background of immune activation that makes vascular inflammation more likely. In such circumstances, the arteries become collateral targets of a broader immune disturbance.
It is also important to distinguish polyarteritis nodosa from vasculitis syndromes associated with hepatitis C, ANCA-associated vasculitis, and other autoimmune diseases. These disorders may affect vessels through different mechanisms, but they are relevant because clinicians must determine whether the artery inflammation is truly PAN or part of another process. The distinction matters biologically because the causes and immune pathways are not identical.
Conclusion
Polyarteritis nodosa develops when medium-sized arteries are injured by immune-mediated inflammation, leading to necrosis, narrowing, aneurysm formation, and impaired blood flow. The strongest known cause is hepatitis B infection, where circulating immune complexes deposit in vessel walls and trigger complement-driven inflammation. In many other cases, the disease is idiopathic, suggesting a combination of genetic susceptibility, immune dysregulation, and unidentified triggers.
Risk is shaped by multiple interacting factors, including infection exposure, genetic background, environmental circumstances, and overall immune status. These influences do not act independently; they converge on a shared biological pathway in which the immune system damages the arterial wall. Understanding those mechanisms explains why polyarteritis nodosa occurs, why it affects some people and not others, and why the disease is fundamentally a disorder of immune-mediated vascular injury.